National Multiple Sclerosis Society is a 501(c)(3) organization based in New York, New York, registered in 1947, with $171,750,637 in FY2023 revenue. CharityIndex grades it A, and it directs about 71% of spending to programs.
Revenue (FY2023)
$171.8M
▲ 14.9% vs prior year
Diseases median: $206K
Expenses (FY2023)
$169.1M
Net assets
$127.5M
Employees
1,035
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For National Multiple Sclerosis Society: 71% to programs · $21 to raise $100 earns a B on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For National Multiple Sclerosis Society: 9 mo reserves · +2% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For National Multiple Sclerosis Society: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For National Multiple Sclerosis Society: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
We will cure ms while empowering people affected by ms to live their best lives.
Public education (see schedule o)public education - people with ms can better manage their disease when they have the support and understanding of the people around them-from doctors to employers to family members. that's why we work relentlessly to tell the world what it means to live with ms. we educate the public through the society's awareness campaigns, public service announcements, and momentum, which is the society's flagship magazine distributed quarterly to nearly 500,000 people living with ms, healthcare providers, and supporters of the society. we send bimonthly emails with news and information about ms to 850,000 people and more than 6.2 million people visit the society's website each year to access information and support and get involved.in addition, many people get engaged in conversations and learn more about ms via the society's social media, with more than 1.1 million followers.
Research and scientific studies (see schedule o)research and scientific studies - in fiscal 2024, the society invested $31.2 million to support 271 new and ongoing research projects around the world aimed at stopping ms in its tracks, restoring function, and ending the disease forever. the society engaged 104 expert scientific and peer reviewers to evaluate 369 proposals for research grants, fellowships and early career awards, commercial research and development agreements, and targeted research grants. we also engaged 15 lay community reviewers to help the society identify the most promising and appropriate research investments.research priority areas to drive breakthroughs to a cure include: accelerating promising research to empower people affected by ms to live their best lives and advance the pathways to ms cures roadmap, including: stopping disease activity and progression through precision medicine and early detection; restoring what's been lost by reversing symptoms and disability through regeneration and functional recovery enhanced by rehabilitation and wellness; and ending the disease through prevention by limiting exposure to risk factors across the population and for those most at-risk.
Professional education and training - the society wants scientists and healthcare professionals to be aware of and trained in ms so that the very best expertise worldwide is engaged in finding treatments and solutions for everyone with ms. this includes activities and programs designed to improve the knowledge, skills, and critical judgement of scientists, physicians and other healthcare professionals engaged (directly or indirectly) in providing services to people living with ms by keeping them abreast of new diagnostic techniques and therapies. in fiscal 2024, 86 clinicians, who provide care for approximately 12,500 people with ms, participated in echo ms, which is a continuing medical education program that establishes a peer-to-peer knowledge sharing network to improve overall health outcomes for individuals with ms. 91% of participants reported that they will be making a change to their clinical practice as a result of the program. as of 2024, the society has funded the training of 115 physicians to become ms specialists who are now providing care for nearly 18,000 people living with ms.
Revenue grew from $116.0M (FY2013) to $171.8M (FY2023) across 10 reported years.
Financial snapshot
Operating margin
1.6%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$201.1M
Total liabilities
$73.6M
Net assets
$127.5M
Salaries & benefits
$94.3M
56% of expenses
Board members
30
29 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $171,750,637▲14.9% | $169,076,414▼2.2% | $127,493,073▲16.4% | $201,117,763▲9.2% | 990 |
| 2022 | $149,451,246▼13.1% | $172,885,857▲8.3% | $109,538,849▼11.9% | $184,229,514▼0.7% | 990 |
| 2021 | $171,945,464▲17.4% | $159,668,291▲15.3% | $124,393,791▼7.3% | $185,523,085▼7.9% | 990 |
| 2020 | $146,424,652▼5.7% | $138,426,378▼12.7% | $134,223,635▲15.9% | $201,483,349▲16.2% | 990 |
| 2019 | $155,230,514▼21.2% | $158,593,669▼12.5% | $115,831,667▼2.3% | $173,433,035▼6.1% | 990 |
| 2018 | $196,889,837▲8.6% | $181,293,702▼2.3% | $118,554,707▲43.8% | $184,662,971▲18.4% | 990 |
| 2016 | $181,247,871▲67.1% | $185,525,045▲57.9% | $82,442,704▲243% | $155,990,278▲41.4% | 990 |
| 2015 | $108,435,816▼4.5% | $117,517,772▲0.2% | $24,028,739▼9.0% | $110,314,180▼8.7% | 990 |
| 2014 | $113,580,591▼2.1% | $117,323,083▲7.8% | $26,403,515▼18.5% | $120,813,206▲15.8% | 990 |
| 2013 | $115,972,436 | $108,828,463▲4.4% | $32,414,675▲18.8% | $104,343,829▲19.9% | 990 |
| 2012 | — | $104,291,401▲3.1% | $27,275,021▲8.5% | $87,051,124▲11.0% | 990 |
| 2011 | — | $101,141,538▲3.1% | $25,140,258▲2.8% | $78,420,407▲3.2% | 990 |
| 2010 | — | $98,147,301▲6.0% | $24,461,856▼12.0% | $76,020,323▲6.6% | 990 |
| 2009 | — | $92,583,603 | $27,802,438 | $71,339,386 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Tami Caesar Thru 122023 — $704,634 (0.42% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Tami Caesar Thru 122023 | Chief Operating Officer | 40 | $704,634 |
| Cynthia Zagieboylo | President & Ceo (thru 07/2024) | 40 | $630,435 |
| Lisa Goldfarb Thru 052024 | Chief Ppl, Vol & Comm Eng Officer | 40 | $391,879 |
| Timothy Coetzee | President & Ceo (as of 07/2024) | 40 | $385,380 |
| Jennifer Lee | Evp, Development | 40 | $292,165 |
| Phyllis Robsham Thru 072024 | Evp, Community Leadership | 40 | $277,045 |
| Cynthia Bertrando | Chief Financial Officer | 40 | $275,591 |
| Bari Talente | Evp, Advocacy & Healthcare Access | 40 | $271,742 |
| Whitnie Gladden | General Counsel | 40 | $270,835 |
| Bruce Bebo | Evp, Research | 40 | $233,185 |
| Ron Zwerin Thru 062024 | Evp, Mkt, Brand & Communications | 40 | $230,421 |
| Rebecca Fehlig | Evp, Operations (thru 07/2024) | 40 | $222,208 |
| Ronda Krier | Evp, Technology | 40 | $217,874 |
| Karen Mariner | Evp, Programs & Support | 40 | $194,331 |
| Misty Flowers As of 062024 | Evp, Finance & Operations | 40 | $163,811 |
| Graham Mcreynolds | Former Avp, Global Initiatives | 0 | $122,590 |
| Andrea Lindsley | Director (as of 11/2023) | 5 | — |
| Andy Harris | Director | 5 | — |
| Bonnie Higgins | Vice Chair | 5 | — |
| Caroline Whitacre | Vice Chair | 5 | — |
| Contractor | Services | Paid |
|---|---|---|
| Merkle Inc | See Schedule O | $9,988,394 |
| Slalom Inc | It Professional Services | $3,424,178 |
| Global Cloud Ltd | It/processing Services | $1,568,667 |
| Provident Contruction Inc | Construction | $849,159 |
| Intecrowd LLC | It Professional Services | $754,004 |
1,207 grants to National Multiple Sclerosis Society totaling $103.4M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Paypal Charitable Giving Fund | General support | 2024 | $5,533,113 |
| American Online Giving Foundation Inc | General support | 2024 | $3,115,509 |
| Charities Aid Foundation America | Charitable donation | 2024 | $885,840 |
| National Christian Charitable Foundation | Medical research | 2024 | $689,425 |
| Mile High United Way Inc | Other | 2024 | $517,396 |
| Mile High United Way Inc | Other | 2024 | $517,396 |
| Greater Houston Community Foundation | Health | 2024 | $216,628 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2024 | $202,674 |
| United Way of Greater St Louis Inc | All-health and well-being; ttp-health and well-being | 2024 | $164,164 |
| Pga Tour Inc | General support | 2024 | $162,941 |
| Bny Mellon Charitable Gift Fund | To further the organization's exempt purpose | 2024 | $146,250 |
| American Endowment Foundation | Disease/disorder | 2024 | $135,690 |
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2024 | $123,694 |
| Providence Health & Services Oregon | Operational support | 2024 | $107,500 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $105,000 |
86 grants totaling $23.4M in FY2023 — showing the 15 largest. All grants made by National Multiple Sclerosis Society →
| Recipient | Purpose | Amount |
|---|---|---|
| The Cleveland Clinic Foundation | Research | $1,360,586 |
| University of Utah | Research | $1,285,905 |
| University of California San Francisco | Research | $1,170,335 |
| Trustees of Columbia University | Research | $1,160,387 |
| Johns Hopkins University | Research | $1,149,283 |
| Yale University | Research | $883,888 |
| The Board of Trustees of the Leland Stanford Junior University | Research | $741,761 |
| Regents of the University of Colorado | Research | $721,158 |
| Mass General Brigham Incorporated | Research | $714,496 |
| Weill Cornell Medical College | Research | $564,561 |
| Trustees of the University of Pennsylvania | Research | $537,646 |
| Empire Discovery Institute Inc | Research | $506,837 |
| The Board of Trustees of the University of Illinois | Research | $482,342 |
| Accelerated Cure Project Inc | Research | $479,172 |
| Kessler Foundation Inc | Research | $434,893 |
Explore more
Data for National Multiple Sclerosis Society (EIN 13-5661935) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.